In patients with low-renin hypertension, the antihypertensive effects of captopril are attributed to the induction of the release of endogenous vasodilating prostaglandins, while in normal renin hypertension, a prime antihypertensive mechanism is based on inhibition of the renin-angiotensin system [308,309]. This evidence concerns the gene REN and hypertensive disorder.